Skip to main navigation Skip to search Skip to main content

Identification and management of nonsystematic cross-commodity data: Toward best practice

  • Mark J. Rzeszutek
  • , Sean D. Regnier
  • , Brent A. Kaplan
  • , Haily K. Traxler
  • , Jeffrey S. Stein
  • , Devin C. Tomlinson
  • , Mikhail N. Koffarnus

Research output: Contribution to journalArticlepeer-review

Abstract

Data systematicity has been an important area of consideration for behavioral economic demand. Stein et al. (2015) introduced criteria and an accompanying algorithm to aid researchers in identifying data series that may be considered "nonsystematic"-that is, data that may not follow empirically based assumptions such as an overall decrease in consumption as the cost of a commodity increases and consistency in decreases in consumption. However, those criteria and algorithm are only directly applicable to own-price demand, or demand for a commodity that is increasing in price. Cross-price demand, or demand for a second commodity that changes as a function of some other commodity, does not have a similar set of criteria or algorithm for assessing cross-commodity demand systematicity. Cross-price or cross-commodity demand is useful in understanding how changes in one substance or commodity may change the consumption of another substance or commodity. Thus, we extend Stein et al.'s criteria and algorithm to classify if a cross-commodity can be considered a substitute, complement, or independent, and then assess its systematicity based on its classification. We demonstrate this algorithm on three different cross-commodity demand data sets and describe important considerations regarding data exclusions to prevent biasing results from own-price and cross-price demand. (PsycInfo Database Record (c) 2026 APA, all rights reserved).

Original languageEnglish
Pages (from-to)363-373
Number of pages11
JournalExperimental and Clinical Psychopharmacology
Volume34
Issue number4
DOIs
StatePublished - Aug 1 2026

Funding

All authors have no known conflicts of interest to disclose. Mark J. Rzeszutek's time was supported by the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (NIH; Grant K99AA031309). Sean D. Regnier's time was supported by the National Institute on Drug Abuse, NIH (Grant K99DA060267). Some of the research reported was supported by Grant U54DA058256 (awarded to Mikhail N. Koffarnus) from the NIH and U.S. Food and Drug Administration Center for Tobacco Products. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the U.S. Food and Drug Administration. The funding sources did not have a role in writing this article or in the decision to submit it for publication.

FundersFunder number
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (NIH)K99AA031309
National Institute on Drug Abuse, NIHK99DA060267
NIHU54DA058256
U.S. Food and Drug Administration Center for Tobacco Products

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    ASJC Scopus subject areas

    • Pharmacology
    • Psychiatry and Mental health
    • Pharmacology (medical)

    Fingerprint

    Dive into the research topics of 'Identification and management of nonsystematic cross-commodity data: Toward best practice'. Together they form a unique fingerprint.

    Cite this